IL195066A0 - Cancer-related nucleic acids - Google Patents

Cancer-related nucleic acids

Info

Publication number
IL195066A0
IL195066A0 IL195066A IL19506608A IL195066A0 IL 195066 A0 IL195066 A0 IL 195066A0 IL 195066 A IL195066 A IL 195066A IL 19506608 A IL19506608 A IL 19506608A IL 195066 A0 IL195066 A0 IL 195066A0
Authority
IL
Israel
Prior art keywords
cancer
nucleic acids
related nucleic
acids
nucleic
Prior art date
Application number
IL195066A
Other languages
English (en)
Original Assignee
Rosetta Genomics Ltd
Ranit Aharonov
Nitzsn Rosenfeld
Hila Benjamin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/418,870 external-priority patent/US7825229B2/en
Priority claimed from US11/418,875 external-priority patent/US7592441B2/en
Priority claimed from US11/418,718 external-priority patent/US20070259349A1/en
Priority claimed from US11/429,720 external-priority patent/US7642348B2/en
Application filed by Rosetta Genomics Ltd, Ranit Aharonov, Nitzsn Rosenfeld, Hila Benjamin filed Critical Rosetta Genomics Ltd
Publication of IL195066A0 publication Critical patent/IL195066A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL195066A 2006-05-04 2008-11-03 Cancer-related nucleic acids IL195066A0 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US11/418,870 US7825229B2 (en) 2005-03-25 2006-05-04 Lung cancer-related nucleic acids
US11/418,875 US7592441B2 (en) 2004-10-04 2006-05-04 Liver cancer-related nucleic acids
US11/418,718 US20070259349A1 (en) 2006-05-04 2006-05-04 Bladder cancer-related nucleic acids
US11/429,720 US7642348B2 (en) 2004-10-04 2006-05-08 Prostate cancer-related nucleic acids
US82524706P 2006-09-11 2006-09-11
PCT/IB2007/003116 WO2007148235A2 (fr) 2006-05-04 2007-05-04 Acides nucléiques apparentés au cancer

Publications (1)

Publication Number Publication Date
IL195066A0 true IL195066A0 (en) 2011-08-01

Family

ID=38833834

Family Applications (1)

Application Number Title Priority Date Filing Date
IL195066A IL195066A0 (en) 2006-05-04 2008-11-03 Cancer-related nucleic acids

Country Status (2)

Country Link
IL (1) IL195066A0 (fr)
WO (1) WO2007148235A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563252B2 (en) 2004-05-14 2013-10-22 Rosetta Genomics Ltd. Methods for distinguishing between lung squamous carcinoma and other non small cell lung cancers
JP2010519899A (ja) * 2007-03-01 2010-06-10 ロゼッタ ゲノミックス エルティーディー． 肺扁平上皮癌とその他の非小細胞肺癌とを見分けるための方法
EP2280078B1 (fr) * 2008-03-27 2016-05-18 Kuroda, Masahiko Marqueur pour la détermination du cancer du sein, méthode d'essai, et kit d'essai
JP5750710B2 (ja) * 2008-04-30 2015-07-22 日本電気株式会社 癌マーカー、それを用いた癌の評価方法および評価試薬
US20110160086A1 (en) * 2008-08-06 2011-06-30 Rosetta Genomics Ltd. Gene expression signature for classification of kidney tumors
US9068232B2 (en) * 2008-08-06 2015-06-30 Rosetta Genomics Ltd. Gene expression signature for classification of kidney tumors
WO2010018563A2 (fr) * 2008-08-12 2010-02-18 Rosetta Genomics Ltd. Compositions et procédés de pronostic d'un lymphome
EP2326730B1 (fr) 2008-08-19 2014-03-19 Maine Institute For Human Genetics And Health Micro-arn (arnmi) et neurofibromatose de type 1 : un rôle en diagnostic et thérapie
US20120053224A1 (en) * 2008-12-10 2012-03-01 Universitat Regensburg Compositions and methods for micro-rna expression profiling of cancer stem cells
US9150919B2 (en) * 2009-04-16 2015-10-06 Padma Arunachalam Methods and compositions to detect and differentiate small RNAs in RNA maturation pathway
EP2460005A4 (fr) * 2009-07-31 2012-11-21 Translational Genomics Res Inst Méthodes d évaluation du risque de progression d un cancer
WO2011024157A1 (fr) * 2009-08-23 2011-03-03 Rosetta Genomics Ltd. Séquences d'acides nucléiques liées au cancer
ES2631458T3 (es) 2010-03-04 2017-08-31 Interna Technologies B.V. Molécula de ARNmi definida por su fuente y sus usos terapéuticos en el cáncer asociado a la EMT
JP6242213B2 (ja) 2010-03-29 2017-12-06 アブラクシス バイオサイエンス， エルエルシー 薬物送達および治療用薬剤の有効性を向上させる方法
WO2011154008A1 (fr) 2010-06-11 2011-12-15 Rigshospitalet Classification de micro-arn de néoplasie folliculaire de la thyroïde
JP5755849B2 (ja) * 2010-07-06 2015-07-29 東レ株式会社 胃がんの補助化学療法感受性判定用組成物又はキット
JP6155194B2 (ja) 2010-11-17 2017-06-28 インターペース ダイアグノスティックス リミテッド ライアビリティ カンパニー 良性甲状腺新生物と悪性甲状腺新生物を区別するためのバイオマーカーとしてのｍｉＲＮＡ
WO2012161124A1 (fr) * 2011-05-20 2012-11-29 国立大学法人愛媛大学 Composition contenant un micro arn ou système d'expression associé
ITRM20110685A1 (it) * 2011-12-23 2013-06-24 Internat Ct For Genetic En Gineering And Microrna per la rigenerazione cardiaca attraverso l induzione della proliferazione dei miociti cardiaci
WO2017073689A1 (fr) * 2015-10-30 2017-05-04 国立大学法人鳥取大学 Molécule d'arn pour la réparation de dommages à l'adn

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7683036B2 (en) * 2003-07-31 2010-03-23 Regulus Therapeutics Inc. Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Also Published As

Publication number Publication date
WO2007148235A2 (fr) 2007-12-27
WO2007148235A3 (fr) 2009-04-30

Similar Documents

Publication Publication Date Title
IL195066A0 (en) Cancer-related nucleic acids
GB0706243D0 (en) Modified nucleic acids
EP2094850A4 (fr) Protéine kinases liées au cancer
EP1988750A4 (fr) Element chauffant plat
GB0603160D0 (en) Nucleic acid
EP1982167A4 (fr) Biocapteur
IL194892A0 (en) Nonseparation assay methods
EP2021778A4 (fr) Procedes de dosage sans separation
EP2123752A4 (fr) Nouvel acide nucléique
EP2077326A4 (fr) Nouvel acide nucléique
PL2041282T3 (pl) Kwasy nukleinowe wiążące sdf-i
EP2017608A4 (fr) Biocapteur
GB2456119B (en) Heating system
IL196268A0 (en) Assay methods
EP2087133A4 (fr) Hybridation perfectionnée d'acides nucléiques
EP2017607A4 (fr) Biocapteur
GB0619208D0 (en) Easy tile
GB0602061D0 (en) Heater
GB0622144D0 (en) Biosensor
EP2047267A4 (fr) Biodétecteur
EP1981985A4 (fr) Procedes pour puces a adn
GB0706631D0 (en) Nucleic acids and libraries
PT1918649T (pt) Sistema de aquecimento
GB0621095D0 (en) Assay method
HU0600159D0 (en) Kvantitative pcr